Approvals/TGA/TEPMETKO tepotinib 225 mg (as hydrochloride monohydrate) tablet blister pack

Approved

STANDARD

TEPMETKO tepotinib 225 mg (as hydrochloride monohydrate) tablet blister pack

Merck Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: b1f50ac9ef76fbc6
Product Name: TEPMETKO tepotinib 225 mg (as hydrochloride monohydrate) tablet blister pack
Artg Id: 370977
Artg Name: TEPMETKO tepotinib 225 mg (as hydrochloride monohydrate) tablet blister pack
Sponsor: Merck Healthcare Pty Ltd
Company Detail Path: /organization/merck-healthcare-pty-ltd
Artg Date: 2022-01-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/2695cb061466fffc36481ffdc9ee9983.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/5b6470f76c390a57f2ca91ace15f396a.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

b1f50ac9ef76fbc6

Type

Standard